View ValuationSatellite ChemicalLtd 향후 성장Future 기준 점검 2/6Satellite ChemicalLtd (는) 각각 연간 16.7% 및 7.9% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 16.7% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 20.3% 로 예상됩니다.핵심 정보16.7%이익 성장률16.73%EPS 성장률Chemicals 이익 성장30.1%매출 성장률7.9%향후 자기자본이익률20.34%애널리스트 커버리지Good마지막 업데이트28 Apr 2026최근 향후 성장 업데이트Major Estimate Revision • Apr 20Consensus EPS estimates increase by 17%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from CN¥51.9b to CN¥55.4b. EPS estimate increased from CN¥2.38 to CN¥2.77 per share. Net income forecast to grow 59% next year vs 50% growth forecast for Chemicals industry in China. Consensus price target up from CN¥32.20 to CN¥34.78. Share price fell 13% to CN¥26.26 over the past week.Major Estimate Revision • Mar 30Consensus EPS estimates increase by 21%, revenue downgradedThe consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from CN¥53.1b to CN¥51.9b. EPS estimate rose from CN¥1.97 to CN¥2.38. Net income forecast to grow 51% next year vs 50% growth forecast for Chemicals industry in China. Consensus price target up from CN¥25.34 to CN¥32.20. Share price rose 11% to CN¥28.56 over the past week.Price Target Changed • Mar 24Price target increased by 11% to CN¥27.22Up from CN¥24.46, the current price target is an average from 5 analysts. New target price is approximately in line with last closing price of CN¥26.02. Stock is up 20% over the past year. The company is forecast to post earnings per share of CN¥2.32 for next year compared to CN¥1.58 last year.Price Target Changed • Feb 03Price target increased by 9.2% to CN¥24.46Up from CN¥22.40, the current price target is an average from 5 analysts. New target price is 8.4% above last closing price of CN¥22.57. Stock is up 13% over the past year. The company is forecast to post earnings per share of CN¥1.53 for next year compared to CN¥1.80 last year.Major Estimate Revision • Oct 31Consensus EPS estimates fall by 15%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥49.8b to CN¥47.1b. EPS estimate also fell from CN¥1.86 per share to CN¥1.58 per share. Net income forecast to grow 14% next year vs 51% growth forecast for Chemicals industry in China. Consensus price target down from CN¥23.58 to CN¥22.16. Share price was steady at CN¥17.91 over the past week.Price Target Changed • Feb 26Price target increased by 7.4% to CN¥24.69Up from CN¥22.99, the current price target is an average from 6 analysts. New target price is 19% above last closing price of CN¥20.75. Stock is up 30% over the past year. The company is forecast to post earnings per share of CN¥2.03 for next year compared to CN¥1.81 last year.모든 업데이트 보기Recent updatesDeclared Dividend • Jun 08Dividend of CN¥0.50 announcedShareholders will receive a dividend of CN¥0.50. Ex-date: 12th June 2026 Payment date: 12th June 2026 Dividend yield will be 2.1%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (29% earnings payout ratio) and cash flows (22% cash payout ratio). The dividend has increased by an average of 32% per year over the past 9 years. However, payments have been volatile during that time. EPS is expected to grow by 59% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Major Estimate Revision • Apr 20Consensus EPS estimates increase by 17%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from CN¥51.9b to CN¥55.4b. EPS estimate increased from CN¥2.38 to CN¥2.77 per share. Net income forecast to grow 59% next year vs 50% growth forecast for Chemicals industry in China. Consensus price target up from CN¥32.20 to CN¥34.78. Share price fell 13% to CN¥26.26 over the past week.공시 • Mar 31Satellite Chemical Co.,Ltd. to Report Q1, 2026 Results on Apr 14, 2026Satellite Chemical Co.,Ltd. announced that they will report Q1, 2026 results on Apr 14, 2026Major Estimate Revision • Mar 30Consensus EPS estimates increase by 21%, revenue downgradedThe consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from CN¥53.1b to CN¥51.9b. EPS estimate rose from CN¥1.97 to CN¥2.38. Net income forecast to grow 51% next year vs 50% growth forecast for Chemicals industry in China. Consensus price target up from CN¥25.34 to CN¥32.20. Share price rose 11% to CN¥28.56 over the past week.Price Target Changed • Mar 24Price target increased by 11% to CN¥27.22Up from CN¥24.46, the current price target is an average from 5 analysts. New target price is approximately in line with last closing price of CN¥26.02. Stock is up 20% over the past year. The company is forecast to post earnings per share of CN¥2.32 for next year compared to CN¥1.58 last year.Reported Earnings • Mar 24Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: CN¥1.58 (down from CN¥1.80 in FY 2024). Revenue: CN¥46.1b (flat on FY 2024). Net income: CN¥5.31b (down 13% from FY 2024). Profit margin: 12% (down from 13% in FY 2024). Revenue missed analyst estimates by 2.5%. Earnings per share (EPS) exceeded analyst estimates by 3.4%. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.공시 • Mar 23Satellite Chemical Co.,Ltd., Annual General Meeting, Apr 13, 2026Satellite Chemical Co.,Ltd., Annual General Meeting, Apr 13, 2026, at 14:00 China Standard Time. Location: No. 196, Fuqiang Road, Nanhu District, Jiaxing, Zhejiang ChinaNew Risk • Mar 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.9% average weekly change).Buy Or Sell Opportunity • Mar 10Now 21% undervaluedOver the last 90 days, the stock has risen 56% to CN¥25.97. The fair value is estimated to be CN¥32.74, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has grown by 27%. Revenue is forecast to grow by 19% in 2 years. Earnings are forecast to grow by 25% in the next 2 years.Valuation Update With 7 Day Price Move • Mar 06Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥26.91, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 26x in the Chemicals industry in China. Total returns to shareholders of 76% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥32.29 per share.Price Target Changed • Feb 03Price target increased by 9.2% to CN¥24.46Up from CN¥22.40, the current price target is an average from 5 analysts. New target price is 8.4% above last closing price of CN¥22.57. Stock is up 13% over the past year. The company is forecast to post earnings per share of CN¥1.53 for next year compared to CN¥1.80 last year.Valuation Update With 7 Day Price Move • Jan 23Investor sentiment improves as stock rises 19%After last week's 19% share price gain to CN¥22.18, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 31% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥30.35 per share.공시 • Dec 31Satellite Chemical Co.,Ltd. to Report Fiscal Year 2025 Results on Mar 24, 2026Satellite Chemical Co.,Ltd. announced that they will report fiscal year 2025 results on Mar 24, 2026Major Estimate Revision • Oct 31Consensus EPS estimates fall by 15%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥49.8b to CN¥47.1b. EPS estimate also fell from CN¥1.86 per share to CN¥1.58 per share. Net income forecast to grow 14% next year vs 51% growth forecast for Chemicals industry in China. Consensus price target down from CN¥23.58 to CN¥22.16. Share price was steady at CN¥17.91 over the past week.Reported Earnings • Oct 25Third quarter 2025 earnings: EPS misses analyst expectationsThird quarter 2025 results: EPS: CN¥0.30 (down from CN¥0.49 in 3Q 2024). Revenue: CN¥11.3b (down 12% from 3Q 2024). Net income: CN¥1.01b (down 38% from 3Q 2024). Profit margin: 8.9% (down from 13% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 57%. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.공시 • Sep 30Satellite Chemical Co.,Ltd. to Report Q3, 2025 Results on Oct 25, 2025Satellite Chemical Co.,Ltd. announced that they will report Q3, 2025 results on Oct 25, 2025Reported Earnings • Aug 13Second quarter 2025 earnings: EPS and revenues miss analyst expectationsSecond quarter 2025 results: EPS: CN¥0.35 (up from CN¥0.31 in 2Q 2024). Revenue: CN¥11.1b (up 5.1% from 2Q 2024). Net income: CN¥1.18b (up 14% from 2Q 2024). Profit margin: 11% (in line with 2Q 2024). Revenue missed analyst estimates by 5.2%. Earnings per share (EPS) also missed analyst estimates by 41%. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.공시 • Jul 02Satellite Chemical Co.,Ltd. to Report First Half, 2025 Results on Aug 12, 2025Satellite Chemical Co.,Ltd. announced that they will report first half, 2025 results on Aug 12, 2025Reported Earnings • Apr 25First quarter 2025 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2025 results: EPS: CN¥0.47 (up from CN¥0.30 in 1Q 2024). Revenue: CN¥12.3b (up 40% from 1Q 2024). Net income: CN¥1.57b (up 53% from 1Q 2024). Profit margin: 13% (up from 12% in 1Q 2024). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 24%. Earnings per share (EPS) also surpassed analyst estimates by 25%. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 1% per year.공시 • Apr 16Satellite Chemical Co.,Ltd. Approves Cash Dividend for the Year 2024Satellite Chemical Co.,Ltd. held its Annual General Meeting of 2024 on April 14, 2025, approved cash dividend of CNY5.00000000 per ten shares (tax included) for 2024.공시 • Apr 11Satellite Chemical Co.,Ltd. (SZSE:002648) announces an Equity Buyback for CNY 400 million worth of its shares.Satellite Chemical Co.,Ltd. (SZSE:002648) announces a share repurchase program. Under the program, the company will repurchase up to CNY 400 million worth of its A shares. The repurchase price will not exceed CNY 29.50 per share. The purpose of the buyback is to implement the company’s business partner shareholding plan or other equity incentives plans. The repurchase will be funded through own funds or self-financing. The repurchase period will be not more than 12 months from the approval date.Valuation Update With 7 Day Price Move • Apr 08Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to CN¥17.64, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 9.9% over the past three years.공시 • Mar 31Satellite Chemical Co.,Ltd. to Report Q1, 2025 Results on Apr 15, 2025Satellite Chemical Co.,Ltd. announced that they will report Q1, 2025 results on Apr 15, 2025Board Change • Mar 27High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. VP & Non-Independent Director Jun Gao was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.공시 • Mar 26Satellite Chemical Co.,Ltd. Proposes Final Dividend for 2024Satellite Chemical Co.,Ltd. announced on 25 March 2025 the profit distribution proposal for 2024 as follows: Cash dividend per 10 shares (tax included) of CNY 5.00000000.공시 • Mar 25Satellite Chemical Co.,Ltd., Annual General Meeting, Apr 14, 2025Satellite Chemical Co.,Ltd., Annual General Meeting, Apr 14, 2025, at 14:00 China Standard Time. Location: No. 196, Fuqiang Road, Nanhu District, Jiaxing, Zhejiang ChinaNew Risk • Feb 27New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 80% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (80% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.Price Target Changed • Feb 26Price target increased by 7.4% to CN¥24.69Up from CN¥22.99, the current price target is an average from 6 analysts. New target price is 19% above last closing price of CN¥20.75. Stock is up 30% over the past year. The company is forecast to post earnings per share of CN¥2.03 for next year compared to CN¥1.81 last year.Reported Earnings • Feb 26Full year 2024 earnings released: EPS: CN¥1.81 (vs CN¥1.42 in FY 2023)Full year 2024 results: EPS: CN¥1.81 (up from CN¥1.42 in FY 2023). Revenue: CN¥47.4b (up 14% from FY 2023). Net income: CN¥6.08b (up 27% from FY 2023). Profit margin: 13% (up from 12% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 2% per year.공시 • Dec 31Satellite Chemical Co.,Ltd. to Report Fiscal Year 2024 Results on Mar 25, 2025Satellite Chemical Co.,Ltd. announced that they will report fiscal year 2024 results on Mar 25, 2025Reported Earnings • Oct 22Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2024 results: EPS: CN¥0.49 (up from CN¥0.46 in 3Q 2023). Revenue: CN¥12.9b (up 19% from 3Q 2023). Net income: CN¥1.64b (up 5.4% from 3Q 2023). Profit margin: 13% (down from 14% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) exceeded analyst estimates by 5.1%. Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.공시 • Sep 30Satellite Chemical Co.,Ltd. to Report Q3, 2024 Results on Oct 22, 2024Satellite Chemical Co.,Ltd. announced that they will report Q3, 2024 results on Oct 22, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥17.51, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 7.6% over the past three years.Reported Earnings • Jul 20Second quarter 2024 earnings: EPS misses analyst expectationsSecond quarter 2024 results: EPS: CN¥0.31 (down from CN¥0.33 in 2Q 2023). Revenue: CN¥10.6b (down 2.5% from 2Q 2023). Net income: CN¥1.03b (down 8.5% from 2Q 2023). Profit margin: 9.8% (in line with 2Q 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 36%. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 3% per year.공시 • Jun 29Satellite Chemical Co.,Ltd. to Report First Half, 2024 Results on Jul 18, 2024Satellite Chemical Co.,Ltd. announced that they will report first half, 2024 results on Jul 18, 2024Reported Earnings • Apr 23First quarter 2024 earnings: EPS and revenues miss analyst expectationsFirst quarter 2024 results: EPS: CN¥0.30 (up from CN¥0.21 in 1Q 2023). Revenue: CN¥8.80b (down 6.5% from 1Q 2023). Net income: CN¥1.02b (up 45% from 1Q 2023). Profit margin: 12% (up from 7.5% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 20%. Earnings per share (EPS) also missed analyst estimates by 36%. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.공시 • Mar 30Satellite Chemical Co.,Ltd. to Report Q1, 2024 Results on Apr 23, 2024Satellite Chemical Co.,Ltd. announced that they will report Q1, 2024 results on Apr 23, 2024공시 • Mar 26Satellite Chemical Co.,Ltd., Annual General Meeting, Apr 15, 2024Satellite Chemical Co.,Ltd., Annual General Meeting, Apr 15, 2024, at 13:30 China Standard Time. Location: The Company's Meeting Room, Jiaxing, Zhejiang ChinaNew Risk • Mar 12New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 86% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (86% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.Reported Earnings • Mar 12Full year 2023 earnings released: EPS: CN¥1.43 (vs CN¥0.91 in FY 2022)Full year 2023 results: EPS: CN¥1.43 (up from CN¥0.91 in FY 2022). Revenue: CN¥40.7b (up 10.0% from FY 2022). Net income: CN¥4.80b (up 57% from FY 2022). Profit margin: 12% (up from 8.3% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.공시 • Dec 30Satellite Chemical Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 26, 2024Satellite Chemical Co.,Ltd. announced that they will report fiscal year 2023 results on Mar 26, 2024Reported Earnings • Oct 25Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2023 results: EPS: CN¥0.46 (up from CN¥0.071 in 3Q 2022). Revenue: CN¥10.9b (up 21% from 3Q 2022). Net income: CN¥1.55b (up CN¥1.32b from 3Q 2022). Profit margin: 14% (up from 2.6% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 12%. Earnings per share (EPS) exceeded analyst estimates by 23%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.공시 • Sep 30Satellite Chemical Co.,Ltd. to Report Q3, 2023 Results on Oct 25, 2023Satellite Chemical Co.,Ltd. announced that they will report Q3, 2023 results on Oct 25, 2023Reported Earnings • Jul 18Second quarter 2023 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2023 results: EPS: CN¥0.34 (down from CN¥0.37 in 2Q 2022). Revenue: CN¥10.6b (flat on 2Q 2022). Net income: CN¥1.13b (down 10% from 2Q 2022). Profit margin: 11% (down from 12% in 2Q 2022). Revenue exceeded analyst estimates by 2.8%. Earnings per share (EPS) also surpassed analyst estimates by 11%. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.공시 • Jul 01Satellite Chemical Co.,Ltd. to Report First Half, 2023 Results on Jul 18, 2023Satellite Chemical Co.,Ltd. announced that they will report first half, 2023 results on Jul 18, 2023공시 • May 06Satellite Chemical Co.,Ltd., Annual General Meeting, May 19, 2023Satellite Chemical Co.,Ltd., Annual General Meeting, May 19, 2023, at 09:30 China Standard Time. Agenda: To consider 2022 work report of the board of directors; to consider 2022 work report of the supervisory committee; to consider 2022 annual accounts; to consider Launching foreign exchange hedging business; and to discuss other matters.Reported Earnings • Apr 29First quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.45 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.21 (down from CN¥0.45 in 1Q 2022). Revenue: CN¥9.42b (up 16% from 1Q 2022). Net income: CN¥707.2m (down 54% from 1Q 2022). Profit margin: 7.5% (down from 19% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has increased by 41% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Dec 05Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥15.83, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 201% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥6.92 per share.Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 9 experienced directors. No highly experienced directors. 3 independent directors (4 non-independent directors). Supervisor Xiaolong Hu was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Nov 07Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥14.29, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 209% over the past three years.Major Estimate Revision • Oct 31Consensus EPS estimates fall by 47%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥40.2b to CN¥36.9b. EPS estimate also fell from CN¥2.25 per share to CN¥1.19 per share. Net income forecast to grow 57% next year vs 43% growth forecast for Chemicals industry in China. Consensus price target down from CN¥25.54 to CN¥22.02. Share price fell 3.4% to CN¥12.40 over the past week.Price Target Changed • Oct 26Price target decreased to CN¥23.05Down from CN¥25.54, the current price target is an average from 5 analysts. New target price is 73% above last closing price of CN¥13.34. Stock is down 37% over the past year. The company is forecast to post earnings per share of CN¥1.26 for next year compared to CN¥1.79 last year.Reported Earnings • Oct 25Third quarter 2022 earnings: EPS and revenues miss analyst expectationsThird quarter 2022 results: EPS: CN¥0.53 (down from CN¥0.63 in 3Q 2021). Revenue: CN¥8.96b (down 3.2% from 3Q 2021). Net income: CN¥235.0m (down 89% from 3Q 2021). Profit margin: 2.6% (down from 23% in 3Q 2021). The decrease in margin was primarily driven by higher expenses. Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) also missed analyst estimates by 87%. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.Upcoming Dividend • Oct 06Upcoming dividend of CN¥0.40 per shareEligible shareholders must have bought the stock before 13 October 2022. Payment date: 13 October 2022. Payout ratio is a comfortable 9.0% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of Chinese dividend payers (2.2%). Lower than average of industry peers (1.8%).공시 • Oct 02Satellite Chemical Co.,Ltd. Announces 2022 Interim Profit Distribution Plan, Payable on October 13, 2022Satellite Chemical Co.,Ltd. announced that 2022 interim profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 4.00000000. Record date is 12 October 2022. Ex-date is 13 October 2022. Payment date is 13 October 2022.공시 • Sep 16Satellite Chemical Co.,Ltd. Approves Profit Distribution Plan for 2022Satellite Chemical Co.,Ltd. at its 3rd Extraordinary General Meeting of 2022 held on 14 September 2022 approved 2022 interim profit distribution plan as Cash dividend/10 shares (tax included): CNY4.00000000.Price Target Changed • Sep 08Price target decreased to CN¥35.75Down from CN¥38.56, the current price target is an average from 9 analysts. New target price is 69% above last closing price of CN¥21.10. Stock is down 29% over the past year. The company is forecast to post earnings per share of CN¥3.19 for next year compared to CN¥2.50 last year.Reported Earnings • Sep 01Second quarter 2022 earnings: EPS and revenues miss analyst expectationsSecond quarter 2022 results: EPS: CN¥0.52 (down from CN¥0.57 in 2Q 2021). Revenue: CN¥10.7b (up 49% from 2Q 2021). Net income: CN¥1.26b (down 7.3% from 2Q 2021). Profit margin: 12% (down from 19% in 2Q 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 5.8%. Earnings per share (EPS) also missed analyst estimates by 66%. Over the next year, revenue is forecast to grow 26%, compared to a 38% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 46% per year, which means it is significantly lagging earnings growth.공시 • Aug 31Satellite Chemical Co.,Ltd. Proposes Cash Dividend for the First Half of 2022Satellite Chemical Co.,Ltd. proposed cash dividend/10 shares (tax included) of CNY 4.00000000 for the first half of 2022.Valuation Update With 7 Day Price Move • Aug 12Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥25.71, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 318% over the past three years.Price Target Changed • Jun 07Price target increased to CN¥42.26Up from CN¥38.55, the current price target is an average from 9 analysts. New target price is 54% above last closing price of CN¥27.43. Stock is up 9.0% over the past year. The company is forecast to post earnings per share of CN¥3.26 for next year compared to CN¥2.50 last year.공시 • May 28Satellite Chemical Co.,Ltd. Announces 2021 Final Profit Distribution, Payable on June 06, 2022Satellite Chemical Co.,Ltd. announced 2021 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 3.49303300. Record date is 02 June 2022. Ex-date is 06 June 2022. Payment date is 06 June 2022.Board Change • May 12Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 9 experienced directors. No highly experienced directors. 3 independent directors (4 non-independent directors). Supervisor Xiaolong Hu was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Apr 28First quarter 2022 earnings: EPS and revenues miss analyst expectationsFirst quarter 2022 results: EPS: CN¥0.89 (up from CN¥0.44 in 1Q 2021). Revenue: CN¥8.14b (up 125% from 1Q 2021). Net income: CN¥1.52b (up 98% from 1Q 2021). Profit margin: 19% (down from 21% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) also missed analyst estimates by 5.6%. Over the next year, revenue is forecast to grow 34%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth.공시 • Apr 13Satelltte Chemical Co., Ltd. Approves Cash Dividend for the Year 2021Satelltte Chemical Co., Ltd. at its annual general meeting held on April 11, 2022, approved cash dividend per ten shares (tax included) of CNY 3.50000000 for the year 2021.Price Target Changed • Oct 26Price target increased to CN¥52.91Up from CN¥40.30, the current price target is an average from 9 analysts. New target price is 25% above last closing price of CN¥42.31. Stock is up 179% over the past year. The company is forecast to post earnings per share of CN¥3.23 for next year compared to CN¥1.09 last year.Reported Earnings • Oct 23Third quarter 2021 earnings released: EPS CN¥1.24 (vs CN¥0.29 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥9.25b (up 233% from 3Q 2020). Net income: CN¥2.13b (up 398% from 3Q 2020). Profit margin: 23% (up from 15% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has increased by 80% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to CN¥36.70, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 370% over the past three years.Valuation Update With 7 Day Price Move • Sep 14Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥45.92, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 489% over the past three years.Major Estimate Revision • Aug 02Consensus EPS estimates increase to CN¥2.46The consensus outlook for earnings per share (EPS) in 2021 has improved. 2021 revenue forecast increased from CN¥20.7b to CN¥22.5b. EPS estimate increased from CN¥2.04 to CN¥2.46 per share. Net income forecast to grow 42% next year vs 42% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥40.30. Share price rose 3.5% to CN¥39.33 over the past week.Reported Earnings • Jul 27Second quarter 2021 earnings released: EPS CN¥0.80 (vs CN¥0.28 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥7.15b (up 129% from 2Q 2020). Net income: CN¥1.36b (up 213% from 2Q 2020). Profit margin: 19% (up from 14% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has increased by 71% per year, which means it is tracking significantly ahead of earnings growth.Price Target Changed • Jul 03Price target increased to CN¥37.51Up from CN¥30.47, the current price target is an average from 8 analysts. New target price is approximately in line with last closing price of CN¥38.40. Stock is up 226% over the past year.Reported Earnings • Apr 30First quarter 2021 earnings released: EPS CN¥0.62 (vs CN¥0.04 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥3.62b (up 119% from 1Q 2020). Net income: CN¥766.6m (up CN¥726.3m from 1Q 2020). Profit margin: 21% (up from 2.4% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has increased by 50% per year, which means it is tracking significantly ahead of earnings growth.Major Estimate Revision • Apr 19Consensus revenue estimates fall to CN¥20.3bThe consensus outlook for revenues in 2021 has deteriorated. 2021 revenue forecast decreased from CN¥22.6b to CN¥20.3b. EPS estimate fell from CN¥2.63 to CN¥2.50 per share. Net income forecast to grow 85% next year vs 45% growth forecast for Chemicals industry in China. Consensus price target down from CN¥50.88 to CN¥41.49. Share price rose 2.4% to CN¥36.98 over the past week.Price Target Changed • Apr 16Price target decreased to CN¥41.49Down from CN¥50.88, the current price target is an average from 8 analysts. New target price is 14% above last closing price of CN¥36.50. Stock is up 162% over the past year.Reported Earnings • Apr 13Full year 2020 earnings released: EPS CN¥1.52 (vs CN¥1.20 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: CN¥10.8b (flat on FY 2019). Net income: CN¥1.66b (up 31% from FY 2019). Profit margin: 15% (up from 12% in FY 2019). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 37% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Mar 09Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥37.07, the stock is trading at a trailing P/E ratio of 24.4x, down from the previous P/E ratio of 28.8x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 118%.공시 • Feb 24Zhejiang Satellite Petrochemical Co., Ltd. to Report Fiscal Year 2020 Results on Apr 13, 2021Zhejiang Satellite Petrochemical Co., Ltd. announced that they will report fiscal year 2020 results on Apr 13, 2021Is New 90 Day High Low • Feb 08New 90-day high: CN¥43.65The company is up 66% from its price of CN¥26.30 on 10 November 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥2.83 per share.Valuation Update With 7 Day Price Move • Feb 02Investor sentiment improved over the past weekAfter last week's 26% share price gain to CN¥41.78, the stock is trading at a trailing P/E ratio of 35.5x, up from the previous P/E ratio of 28.2x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 174%.Is New 90 Day High Low • Jan 21New 90-day high: CN¥31.50The company is up 52% from its price of CN¥20.79 on 23 October 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.53 per share.Valuation Update With 7 Day Price Move • Jan 08Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥30.10, the stock is trading at a trailing P/E ratio of 25.6x, up from the previous P/E ratio of 22.2x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 68%.Is New 90 Day High Low • Jan 06New 90-day high: CN¥28.67The company is up 41% from its price of CN¥20.27 on 30 September 2020. The Chinese market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.53 per share.공시 • Dec 29Zhejiang Satellite Petrochemical Co., Ltd. Announces Executive ChangesZhejiang Satellite Petrochemical Co., Ltd. announced that at its EGM held on 25 December 2020, it has approved the election of Yang Weidong, Ma Guolin, Yang Yuying and Zhu Xiaodong as non-independent directors. Approved the election of Gao Changyou, Pan Yushuang and Fei Jinhong as independent directors of the company. Approved the election of Tang Wenrong and Hu Xiaolong as non-employee supervisors.Price Target Changed • Nov 20Price target raised to CN¥25.00Up from CN¥22.06, the current price target is an average from 9 analysts. The new target price is close to the current share price of CN¥26.03. As of last close, the stock is up 88% over the past year.이익 및 매출 성장 예측SZSE:002648 - 애널리스트 향후 추정치 및 과거 재무 데이터 (CNY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/202858,96810,3217,84917,746512/31/202756,9169,4376,94216,031612/31/202655,0279,324-2,33916,31153/31/202646,4165,8597,70310,219N/A12/31/202546,0685,3116,9479,607N/A9/30/202548,1446,1349,62411,517N/A6/30/202549,7086,75911,50813,528N/A3/31/202549,1736,6188,99111,528N/A12/31/202445,6486,0727,45010,590N/A9/30/202441,7135,0526,5149,125N/A6/30/202440,5545,0184,6077,234N/A3/31/202440,8305,1145,4097,782N/A12/31/202341,4874,7895,5907,996N/A9/30/202341,3223,4813,5267,419N/A6/30/202338,5622,1259015,121N/A3/31/202338,3672,2621,0685,447N/A1/1/202337,0433,0961,9715,888N/A9/30/202236,3084,7973,4505,690N/A6/30/202236,6016,6794,4346,729N/A3/31/202233,0716,7722,3055,352N/A1/1/202228,5576,007-3953,668N/A9/30/202123,2395,014-5,666865N/A6/30/202116,7703,312-6,194621N/A3/31/202112,7432,387-6,812-492N/A12/31/202010,7731,661-5,797-520N/A9/30/202010,3071,253-3,554-737N/A6/30/202010,3911,190-2,057462N/A3/31/202010,3251,093-1,848749N/A12/31/201910,7791,273N/A1,352N/A9/30/201911,1251,240N/A2,091N/A6/30/201910,8311,171N/A876N/A3/31/201910,3831,047N/A995N/A12/31/201810,029941N/A752N/A9/30/20188,991870N/A167N/A6/30/20188,511785N/A619N/A3/31/20188,026764N/A527N/A12/31/20178,188942N/A572N/A9/30/20177,967903N/A1,285N/A6/30/20177,152775N/A848N/A3/31/20176,166595N/A552N/A12/31/20165,301306N/A742N/A9/30/20164,417-112N/A892N/A6/30/20164,190-307N/A794N/A3/31/20164,394-285N/A1,133N/A12/31/20154,187-437N/A1,253N/A9/30/20154,589-419N/A17N/A6/30/20154,563-265N/A-409N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 002648 의 연간 예상 수익 증가율(16.7%)이 saving rate(2.4%)보다 높습니다.수익 vs 시장: 002648 의 연간 수익(16.7%)이 CN 시장(27%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: 002648 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: 002648 의 수익(연간 7.9%)이 CN 시장(연간 16.5%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: 002648 의 수익(연간 7.9%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 002648의 자본 수익률은 3년 후 20.3%로 높을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/16 20:18종가2026/06/16 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Satellite Chemical Co.,Ltd.는 16명의 분석가가 다루고 있습니다. 이 중 6명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Kaiming FuChina International Capital Corporation LimitedXiaotian XuChina International Capital Corporation Limitednull nullChina Merchants Securities (HK) Co., Ltd13명의 분석가 더 보기
Major Estimate Revision • Apr 20Consensus EPS estimates increase by 17%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from CN¥51.9b to CN¥55.4b. EPS estimate increased from CN¥2.38 to CN¥2.77 per share. Net income forecast to grow 59% next year vs 50% growth forecast for Chemicals industry in China. Consensus price target up from CN¥32.20 to CN¥34.78. Share price fell 13% to CN¥26.26 over the past week.
Major Estimate Revision • Mar 30Consensus EPS estimates increase by 21%, revenue downgradedThe consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from CN¥53.1b to CN¥51.9b. EPS estimate rose from CN¥1.97 to CN¥2.38. Net income forecast to grow 51% next year vs 50% growth forecast for Chemicals industry in China. Consensus price target up from CN¥25.34 to CN¥32.20. Share price rose 11% to CN¥28.56 over the past week.
Price Target Changed • Mar 24Price target increased by 11% to CN¥27.22Up from CN¥24.46, the current price target is an average from 5 analysts. New target price is approximately in line with last closing price of CN¥26.02. Stock is up 20% over the past year. The company is forecast to post earnings per share of CN¥2.32 for next year compared to CN¥1.58 last year.
Price Target Changed • Feb 03Price target increased by 9.2% to CN¥24.46Up from CN¥22.40, the current price target is an average from 5 analysts. New target price is 8.4% above last closing price of CN¥22.57. Stock is up 13% over the past year. The company is forecast to post earnings per share of CN¥1.53 for next year compared to CN¥1.80 last year.
Major Estimate Revision • Oct 31Consensus EPS estimates fall by 15%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥49.8b to CN¥47.1b. EPS estimate also fell from CN¥1.86 per share to CN¥1.58 per share. Net income forecast to grow 14% next year vs 51% growth forecast for Chemicals industry in China. Consensus price target down from CN¥23.58 to CN¥22.16. Share price was steady at CN¥17.91 over the past week.
Price Target Changed • Feb 26Price target increased by 7.4% to CN¥24.69Up from CN¥22.99, the current price target is an average from 6 analysts. New target price is 19% above last closing price of CN¥20.75. Stock is up 30% over the past year. The company is forecast to post earnings per share of CN¥2.03 for next year compared to CN¥1.81 last year.
Declared Dividend • Jun 08Dividend of CN¥0.50 announcedShareholders will receive a dividend of CN¥0.50. Ex-date: 12th June 2026 Payment date: 12th June 2026 Dividend yield will be 2.1%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (29% earnings payout ratio) and cash flows (22% cash payout ratio). The dividend has increased by an average of 32% per year over the past 9 years. However, payments have been volatile during that time. EPS is expected to grow by 59% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Major Estimate Revision • Apr 20Consensus EPS estimates increase by 17%The consensus outlook for earnings per share (EPS) in fiscal year 2026 has improved. 2026 revenue forecast increased from CN¥51.9b to CN¥55.4b. EPS estimate increased from CN¥2.38 to CN¥2.77 per share. Net income forecast to grow 59% next year vs 50% growth forecast for Chemicals industry in China. Consensus price target up from CN¥32.20 to CN¥34.78. Share price fell 13% to CN¥26.26 over the past week.
공시 • Mar 31Satellite Chemical Co.,Ltd. to Report Q1, 2026 Results on Apr 14, 2026Satellite Chemical Co.,Ltd. announced that they will report Q1, 2026 results on Apr 14, 2026
Major Estimate Revision • Mar 30Consensus EPS estimates increase by 21%, revenue downgradedThe consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast fell from CN¥53.1b to CN¥51.9b. EPS estimate rose from CN¥1.97 to CN¥2.38. Net income forecast to grow 51% next year vs 50% growth forecast for Chemicals industry in China. Consensus price target up from CN¥25.34 to CN¥32.20. Share price rose 11% to CN¥28.56 over the past week.
Price Target Changed • Mar 24Price target increased by 11% to CN¥27.22Up from CN¥24.46, the current price target is an average from 5 analysts. New target price is approximately in line with last closing price of CN¥26.02. Stock is up 20% over the past year. The company is forecast to post earnings per share of CN¥2.32 for next year compared to CN¥1.58 last year.
Reported Earnings • Mar 24Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2025 results: EPS: CN¥1.58 (down from CN¥1.80 in FY 2024). Revenue: CN¥46.1b (flat on FY 2024). Net income: CN¥5.31b (down 13% from FY 2024). Profit margin: 12% (down from 13% in FY 2024). Revenue missed analyst estimates by 2.5%. Earnings per share (EPS) exceeded analyst estimates by 3.4%. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.
공시 • Mar 23Satellite Chemical Co.,Ltd., Annual General Meeting, Apr 13, 2026Satellite Chemical Co.,Ltd., Annual General Meeting, Apr 13, 2026, at 14:00 China Standard Time. Location: No. 196, Fuqiang Road, Nanhu District, Jiaxing, Zhejiang China
New Risk • Mar 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.9% average weekly change).
Buy Or Sell Opportunity • Mar 10Now 21% undervaluedOver the last 90 days, the stock has risen 56% to CN¥25.97. The fair value is estimated to be CN¥32.74, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has grown by 27%. Revenue is forecast to grow by 19% in 2 years. Earnings are forecast to grow by 25% in the next 2 years.
Valuation Update With 7 Day Price Move • Mar 06Investor sentiment improves as stock rises 15%After last week's 15% share price gain to CN¥26.91, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 26x in the Chemicals industry in China. Total returns to shareholders of 76% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥32.29 per share.
Price Target Changed • Feb 03Price target increased by 9.2% to CN¥24.46Up from CN¥22.40, the current price target is an average from 5 analysts. New target price is 8.4% above last closing price of CN¥22.57. Stock is up 13% over the past year. The company is forecast to post earnings per share of CN¥1.53 for next year compared to CN¥1.80 last year.
Valuation Update With 7 Day Price Move • Jan 23Investor sentiment improves as stock rises 19%After last week's 19% share price gain to CN¥22.18, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 31% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥30.35 per share.
공시 • Dec 31Satellite Chemical Co.,Ltd. to Report Fiscal Year 2025 Results on Mar 24, 2026Satellite Chemical Co.,Ltd. announced that they will report fiscal year 2025 results on Mar 24, 2026
Major Estimate Revision • Oct 31Consensus EPS estimates fall by 15%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥49.8b to CN¥47.1b. EPS estimate also fell from CN¥1.86 per share to CN¥1.58 per share. Net income forecast to grow 14% next year vs 51% growth forecast for Chemicals industry in China. Consensus price target down from CN¥23.58 to CN¥22.16. Share price was steady at CN¥17.91 over the past week.
Reported Earnings • Oct 25Third quarter 2025 earnings: EPS misses analyst expectationsThird quarter 2025 results: EPS: CN¥0.30 (down from CN¥0.49 in 3Q 2024). Revenue: CN¥11.3b (down 12% from 3Q 2024). Net income: CN¥1.01b (down 38% from 3Q 2024). Profit margin: 8.9% (down from 13% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 57%. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
공시 • Sep 30Satellite Chemical Co.,Ltd. to Report Q3, 2025 Results on Oct 25, 2025Satellite Chemical Co.,Ltd. announced that they will report Q3, 2025 results on Oct 25, 2025
Reported Earnings • Aug 13Second quarter 2025 earnings: EPS and revenues miss analyst expectationsSecond quarter 2025 results: EPS: CN¥0.35 (up from CN¥0.31 in 2Q 2024). Revenue: CN¥11.1b (up 5.1% from 2Q 2024). Net income: CN¥1.18b (up 14% from 2Q 2024). Profit margin: 11% (in line with 2Q 2024). Revenue missed analyst estimates by 5.2%. Earnings per share (EPS) also missed analyst estimates by 41%. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
공시 • Jul 02Satellite Chemical Co.,Ltd. to Report First Half, 2025 Results on Aug 12, 2025Satellite Chemical Co.,Ltd. announced that they will report first half, 2025 results on Aug 12, 2025
Reported Earnings • Apr 25First quarter 2025 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2025 results: EPS: CN¥0.47 (up from CN¥0.30 in 1Q 2024). Revenue: CN¥12.3b (up 40% from 1Q 2024). Net income: CN¥1.57b (up 53% from 1Q 2024). Profit margin: 13% (up from 12% in 1Q 2024). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 24%. Earnings per share (EPS) also surpassed analyst estimates by 25%. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 5% per year whereas the company’s share price has increased by 1% per year.
공시 • Apr 16Satellite Chemical Co.,Ltd. Approves Cash Dividend for the Year 2024Satellite Chemical Co.,Ltd. held its Annual General Meeting of 2024 on April 14, 2025, approved cash dividend of CNY5.00000000 per ten shares (tax included) for 2024.
공시 • Apr 11Satellite Chemical Co.,Ltd. (SZSE:002648) announces an Equity Buyback for CNY 400 million worth of its shares.Satellite Chemical Co.,Ltd. (SZSE:002648) announces a share repurchase program. Under the program, the company will repurchase up to CNY 400 million worth of its A shares. The repurchase price will not exceed CNY 29.50 per share. The purpose of the buyback is to implement the company’s business partner shareholding plan or other equity incentives plans. The repurchase will be funded through own funds or self-financing. The repurchase period will be not more than 12 months from the approval date.
Valuation Update With 7 Day Price Move • Apr 08Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to CN¥17.64, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 9.9% over the past three years.
공시 • Mar 31Satellite Chemical Co.,Ltd. to Report Q1, 2025 Results on Apr 15, 2025Satellite Chemical Co.,Ltd. announced that they will report Q1, 2025 results on Apr 15, 2025
Board Change • Mar 27High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. VP & Non-Independent Director Jun Gao was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
공시 • Mar 26Satellite Chemical Co.,Ltd. Proposes Final Dividend for 2024Satellite Chemical Co.,Ltd. announced on 25 March 2025 the profit distribution proposal for 2024 as follows: Cash dividend per 10 shares (tax included) of CNY 5.00000000.
공시 • Mar 25Satellite Chemical Co.,Ltd., Annual General Meeting, Apr 14, 2025Satellite Chemical Co.,Ltd., Annual General Meeting, Apr 14, 2025, at 14:00 China Standard Time. Location: No. 196, Fuqiang Road, Nanhu District, Jiaxing, Zhejiang China
New Risk • Feb 27New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 80% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (80% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
Price Target Changed • Feb 26Price target increased by 7.4% to CN¥24.69Up from CN¥22.99, the current price target is an average from 6 analysts. New target price is 19% above last closing price of CN¥20.75. Stock is up 30% over the past year. The company is forecast to post earnings per share of CN¥2.03 for next year compared to CN¥1.81 last year.
Reported Earnings • Feb 26Full year 2024 earnings released: EPS: CN¥1.81 (vs CN¥1.42 in FY 2023)Full year 2024 results: EPS: CN¥1.81 (up from CN¥1.42 in FY 2023). Revenue: CN¥47.4b (up 14% from FY 2023). Net income: CN¥6.08b (up 27% from FY 2023). Profit margin: 13% (up from 12% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 4% per year whereas the company’s share price has fallen by 2% per year.
공시 • Dec 31Satellite Chemical Co.,Ltd. to Report Fiscal Year 2024 Results on Mar 25, 2025Satellite Chemical Co.,Ltd. announced that they will report fiscal year 2024 results on Mar 25, 2025
Reported Earnings • Oct 22Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2024 results: EPS: CN¥0.49 (up from CN¥0.46 in 3Q 2023). Revenue: CN¥12.9b (up 19% from 3Q 2023). Net income: CN¥1.64b (up 5.4% from 3Q 2023). Profit margin: 13% (down from 14% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 2.8%. Earnings per share (EPS) exceeded analyst estimates by 5.1%. Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
공시 • Sep 30Satellite Chemical Co.,Ltd. to Report Q3, 2024 Results on Oct 22, 2024Satellite Chemical Co.,Ltd. announced that they will report Q3, 2024 results on Oct 22, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥17.51, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 7.6% over the past three years.
Reported Earnings • Jul 20Second quarter 2024 earnings: EPS misses analyst expectationsSecond quarter 2024 results: EPS: CN¥0.31 (down from CN¥0.33 in 2Q 2023). Revenue: CN¥10.6b (down 2.5% from 2Q 2023). Net income: CN¥1.03b (down 8.5% from 2Q 2023). Profit margin: 9.8% (in line with 2Q 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 36%. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 3% per year.
공시 • Jun 29Satellite Chemical Co.,Ltd. to Report First Half, 2024 Results on Jul 18, 2024Satellite Chemical Co.,Ltd. announced that they will report first half, 2024 results on Jul 18, 2024
Reported Earnings • Apr 23First quarter 2024 earnings: EPS and revenues miss analyst expectationsFirst quarter 2024 results: EPS: CN¥0.30 (up from CN¥0.21 in 1Q 2023). Revenue: CN¥8.80b (down 6.5% from 1Q 2023). Net income: CN¥1.02b (up 45% from 1Q 2023). Profit margin: 12% (up from 7.5% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 20%. Earnings per share (EPS) also missed analyst estimates by 36%. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
공시 • Mar 30Satellite Chemical Co.,Ltd. to Report Q1, 2024 Results on Apr 23, 2024Satellite Chemical Co.,Ltd. announced that they will report Q1, 2024 results on Apr 23, 2024
공시 • Mar 26Satellite Chemical Co.,Ltd., Annual General Meeting, Apr 15, 2024Satellite Chemical Co.,Ltd., Annual General Meeting, Apr 15, 2024, at 13:30 China Standard Time. Location: The Company's Meeting Room, Jiaxing, Zhejiang China
New Risk • Mar 12New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 86% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (86% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
Reported Earnings • Mar 12Full year 2023 earnings released: EPS: CN¥1.43 (vs CN¥0.91 in FY 2022)Full year 2023 results: EPS: CN¥1.43 (up from CN¥0.91 in FY 2022). Revenue: CN¥40.7b (up 10.0% from FY 2022). Net income: CN¥4.80b (up 57% from FY 2022). Profit margin: 12% (up from 8.3% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.
공시 • Dec 30Satellite Chemical Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 26, 2024Satellite Chemical Co.,Ltd. announced that they will report fiscal year 2023 results on Mar 26, 2024
Reported Earnings • Oct 25Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2023 results: EPS: CN¥0.46 (up from CN¥0.071 in 3Q 2022). Revenue: CN¥10.9b (up 21% from 3Q 2022). Net income: CN¥1.55b (up CN¥1.32b from 3Q 2022). Profit margin: 14% (up from 2.6% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 12%. Earnings per share (EPS) exceeded analyst estimates by 23%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Sep 30Satellite Chemical Co.,Ltd. to Report Q3, 2023 Results on Oct 25, 2023Satellite Chemical Co.,Ltd. announced that they will report Q3, 2023 results on Oct 25, 2023
Reported Earnings • Jul 18Second quarter 2023 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2023 results: EPS: CN¥0.34 (down from CN¥0.37 in 2Q 2022). Revenue: CN¥10.6b (flat on 2Q 2022). Net income: CN¥1.13b (down 10% from 2Q 2022). Profit margin: 11% (down from 12% in 2Q 2022). Revenue exceeded analyst estimates by 2.8%. Earnings per share (EPS) also surpassed analyst estimates by 11%. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth.
공시 • Jul 01Satellite Chemical Co.,Ltd. to Report First Half, 2023 Results on Jul 18, 2023Satellite Chemical Co.,Ltd. announced that they will report first half, 2023 results on Jul 18, 2023
공시 • May 06Satellite Chemical Co.,Ltd., Annual General Meeting, May 19, 2023Satellite Chemical Co.,Ltd., Annual General Meeting, May 19, 2023, at 09:30 China Standard Time. Agenda: To consider 2022 work report of the board of directors; to consider 2022 work report of the supervisory committee; to consider 2022 annual accounts; to consider Launching foreign exchange hedging business; and to discuss other matters.
Reported Earnings • Apr 29First quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.45 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.21 (down from CN¥0.45 in 1Q 2022). Revenue: CN¥9.42b (up 16% from 1Q 2022). Net income: CN¥707.2m (down 54% from 1Q 2022). Profit margin: 7.5% (down from 19% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has increased by 41% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Dec 05Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥15.83, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 16x in the Chemicals industry in China. Total returns to shareholders of 201% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥6.92 per share.
Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 9 experienced directors. No highly experienced directors. 3 independent directors (4 non-independent directors). Supervisor Xiaolong Hu was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Nov 07Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥14.29, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 15x in the Chemicals industry in China. Total returns to shareholders of 209% over the past three years.
Major Estimate Revision • Oct 31Consensus EPS estimates fall by 47%The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from CN¥40.2b to CN¥36.9b. EPS estimate also fell from CN¥2.25 per share to CN¥1.19 per share. Net income forecast to grow 57% next year vs 43% growth forecast for Chemicals industry in China. Consensus price target down from CN¥25.54 to CN¥22.02. Share price fell 3.4% to CN¥12.40 over the past week.
Price Target Changed • Oct 26Price target decreased to CN¥23.05Down from CN¥25.54, the current price target is an average from 5 analysts. New target price is 73% above last closing price of CN¥13.34. Stock is down 37% over the past year. The company is forecast to post earnings per share of CN¥1.26 for next year compared to CN¥1.79 last year.
Reported Earnings • Oct 25Third quarter 2022 earnings: EPS and revenues miss analyst expectationsThird quarter 2022 results: EPS: CN¥0.53 (down from CN¥0.63 in 3Q 2021). Revenue: CN¥8.96b (down 3.2% from 3Q 2021). Net income: CN¥235.0m (down 89% from 3Q 2021). Profit margin: 2.6% (down from 23% in 3Q 2021). The decrease in margin was primarily driven by higher expenses. Revenue missed analyst estimates by 1.4%. Earnings per share (EPS) also missed analyst estimates by 87%. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.
Upcoming Dividend • Oct 06Upcoming dividend of CN¥0.40 per shareEligible shareholders must have bought the stock before 13 October 2022. Payment date: 13 October 2022. Payout ratio is a comfortable 9.0% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of Chinese dividend payers (2.2%). Lower than average of industry peers (1.8%).
공시 • Oct 02Satellite Chemical Co.,Ltd. Announces 2022 Interim Profit Distribution Plan, Payable on October 13, 2022Satellite Chemical Co.,Ltd. announced that 2022 interim profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 4.00000000. Record date is 12 October 2022. Ex-date is 13 October 2022. Payment date is 13 October 2022.
공시 • Sep 16Satellite Chemical Co.,Ltd. Approves Profit Distribution Plan for 2022Satellite Chemical Co.,Ltd. at its 3rd Extraordinary General Meeting of 2022 held on 14 September 2022 approved 2022 interim profit distribution plan as Cash dividend/10 shares (tax included): CNY4.00000000.
Price Target Changed • Sep 08Price target decreased to CN¥35.75Down from CN¥38.56, the current price target is an average from 9 analysts. New target price is 69% above last closing price of CN¥21.10. Stock is down 29% over the past year. The company is forecast to post earnings per share of CN¥3.19 for next year compared to CN¥2.50 last year.
Reported Earnings • Sep 01Second quarter 2022 earnings: EPS and revenues miss analyst expectationsSecond quarter 2022 results: EPS: CN¥0.52 (down from CN¥0.57 in 2Q 2021). Revenue: CN¥10.7b (up 49% from 2Q 2021). Net income: CN¥1.26b (down 7.3% from 2Q 2021). Profit margin: 12% (down from 19% in 2Q 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 5.8%. Earnings per share (EPS) also missed analyst estimates by 66%. Over the next year, revenue is forecast to grow 26%, compared to a 38% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 46% per year, which means it is significantly lagging earnings growth.
공시 • Aug 31Satellite Chemical Co.,Ltd. Proposes Cash Dividend for the First Half of 2022Satellite Chemical Co.,Ltd. proposed cash dividend/10 shares (tax included) of CNY 4.00000000 for the first half of 2022.
Valuation Update With 7 Day Price Move • Aug 12Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥25.71, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 318% over the past three years.
Price Target Changed • Jun 07Price target increased to CN¥42.26Up from CN¥38.55, the current price target is an average from 9 analysts. New target price is 54% above last closing price of CN¥27.43. Stock is up 9.0% over the past year. The company is forecast to post earnings per share of CN¥3.26 for next year compared to CN¥2.50 last year.
공시 • May 28Satellite Chemical Co.,Ltd. Announces 2021 Final Profit Distribution, Payable on June 06, 2022Satellite Chemical Co.,Ltd. announced 2021 final profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 3.49303300. Record date is 02 June 2022. Ex-date is 06 June 2022. Payment date is 06 June 2022.
Board Change • May 12Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 9 experienced directors. No highly experienced directors. 3 independent directors (4 non-independent directors). Supervisor Xiaolong Hu was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Apr 28First quarter 2022 earnings: EPS and revenues miss analyst expectationsFirst quarter 2022 results: EPS: CN¥0.89 (up from CN¥0.44 in 1Q 2021). Revenue: CN¥8.14b (up 125% from 1Q 2021). Net income: CN¥1.52b (up 98% from 1Q 2021). Profit margin: 19% (down from 21% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) also missed analyst estimates by 5.6%. Over the next year, revenue is forecast to grow 34%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth.
공시 • Apr 13Satelltte Chemical Co., Ltd. Approves Cash Dividend for the Year 2021Satelltte Chemical Co., Ltd. at its annual general meeting held on April 11, 2022, approved cash dividend per ten shares (tax included) of CNY 3.50000000 for the year 2021.
Price Target Changed • Oct 26Price target increased to CN¥52.91Up from CN¥40.30, the current price target is an average from 9 analysts. New target price is 25% above last closing price of CN¥42.31. Stock is up 179% over the past year. The company is forecast to post earnings per share of CN¥3.23 for next year compared to CN¥1.09 last year.
Reported Earnings • Oct 23Third quarter 2021 earnings released: EPS CN¥1.24 (vs CN¥0.29 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥9.25b (up 233% from 3Q 2020). Net income: CN¥2.13b (up 398% from 3Q 2020). Profit margin: 23% (up from 15% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has increased by 80% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to CN¥36.70, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 370% over the past three years.
Valuation Update With 7 Day Price Move • Sep 14Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥45.92, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 489% over the past three years.
Major Estimate Revision • Aug 02Consensus EPS estimates increase to CN¥2.46The consensus outlook for earnings per share (EPS) in 2021 has improved. 2021 revenue forecast increased from CN¥20.7b to CN¥22.5b. EPS estimate increased from CN¥2.04 to CN¥2.46 per share. Net income forecast to grow 42% next year vs 42% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥40.30. Share price rose 3.5% to CN¥39.33 over the past week.
Reported Earnings • Jul 27Second quarter 2021 earnings released: EPS CN¥0.80 (vs CN¥0.28 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥7.15b (up 129% from 2Q 2020). Net income: CN¥1.36b (up 213% from 2Q 2020). Profit margin: 19% (up from 14% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has increased by 71% per year, which means it is tracking significantly ahead of earnings growth.
Price Target Changed • Jul 03Price target increased to CN¥37.51Up from CN¥30.47, the current price target is an average from 8 analysts. New target price is approximately in line with last closing price of CN¥38.40. Stock is up 226% over the past year.
Reported Earnings • Apr 30First quarter 2021 earnings released: EPS CN¥0.62 (vs CN¥0.04 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥3.62b (up 119% from 1Q 2020). Net income: CN¥766.6m (up CN¥726.3m from 1Q 2020). Profit margin: 21% (up from 2.4% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has increased by 50% per year, which means it is tracking significantly ahead of earnings growth.
Major Estimate Revision • Apr 19Consensus revenue estimates fall to CN¥20.3bThe consensus outlook for revenues in 2021 has deteriorated. 2021 revenue forecast decreased from CN¥22.6b to CN¥20.3b. EPS estimate fell from CN¥2.63 to CN¥2.50 per share. Net income forecast to grow 85% next year vs 45% growth forecast for Chemicals industry in China. Consensus price target down from CN¥50.88 to CN¥41.49. Share price rose 2.4% to CN¥36.98 over the past week.
Price Target Changed • Apr 16Price target decreased to CN¥41.49Down from CN¥50.88, the current price target is an average from 8 analysts. New target price is 14% above last closing price of CN¥36.50. Stock is up 162% over the past year.
Reported Earnings • Apr 13Full year 2020 earnings released: EPS CN¥1.52 (vs CN¥1.20 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: CN¥10.8b (flat on FY 2019). Net income: CN¥1.66b (up 31% from FY 2019). Profit margin: 15% (up from 12% in FY 2019). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 37% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Mar 09Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥37.07, the stock is trading at a trailing P/E ratio of 24.4x, down from the previous P/E ratio of 28.8x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 118%.
공시 • Feb 24Zhejiang Satellite Petrochemical Co., Ltd. to Report Fiscal Year 2020 Results on Apr 13, 2021Zhejiang Satellite Petrochemical Co., Ltd. announced that they will report fiscal year 2020 results on Apr 13, 2021
Is New 90 Day High Low • Feb 08New 90-day high: CN¥43.65The company is up 66% from its price of CN¥26.30 on 10 November 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 12% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥2.83 per share.
Valuation Update With 7 Day Price Move • Feb 02Investor sentiment improved over the past weekAfter last week's 26% share price gain to CN¥41.78, the stock is trading at a trailing P/E ratio of 35.5x, up from the previous P/E ratio of 28.2x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 174%.
Is New 90 Day High Low • Jan 21New 90-day high: CN¥31.50The company is up 52% from its price of CN¥20.79 on 23 October 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.53 per share.
Valuation Update With 7 Day Price Move • Jan 08Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥30.10, the stock is trading at a trailing P/E ratio of 25.6x, up from the previous P/E ratio of 22.2x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 68%.
Is New 90 Day High Low • Jan 06New 90-day high: CN¥28.67The company is up 41% from its price of CN¥20.27 on 30 September 2020. The Chinese market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.53 per share.
공시 • Dec 29Zhejiang Satellite Petrochemical Co., Ltd. Announces Executive ChangesZhejiang Satellite Petrochemical Co., Ltd. announced that at its EGM held on 25 December 2020, it has approved the election of Yang Weidong, Ma Guolin, Yang Yuying and Zhu Xiaodong as non-independent directors. Approved the election of Gao Changyou, Pan Yushuang and Fei Jinhong as independent directors of the company. Approved the election of Tang Wenrong and Hu Xiaolong as non-employee supervisors.
Price Target Changed • Nov 20Price target raised to CN¥25.00Up from CN¥22.06, the current price target is an average from 9 analysts. The new target price is close to the current share price of CN¥26.03. As of last close, the stock is up 88% over the past year.